Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Andreas Trojan"'
Autor:
Andreas Trojan, Emanuele Laurenzi, Stephan Jüngling, Sven Roth, Michael Kiessling, Ziad Atassi, Yannick Kadvany, Meinrad Mannhart, Christian Jackisch, Gerd Kullak-Ublick, Hans Friedrich Witschel
Publikováno v:
Frontiers in Digital Health, Vol 6 (2024)
BackgroundThe use of smartphone apps in cancer patients undergoing systemic treatment can promote the early detection of symptoms and therapy side effects and may be supported by machine learning (ML) for timely adaptation of therapies and reduction
Externí odkaz:
https://doaj.org/article/b73687fc63bc423ea85ada7bc1ad7170
Autor:
Andreas Trojan, Christian Kühne, Michael Kiessling, Johannes Schumacher, Stefan Dröse, Christian Singer, Christian Jackisch, Christoph Thomssen, Gerd A Kullak-Ublick
Publikováno v:
JMIR Formative Research, Vol 8, p e55917 (2024)
BackgroundThe evaluation of electronic patient-reported outcomes (ePROs) is increasingly being used in clinical studies of patients with cancer and enables structured and standardized data collection in patients’ everyday lives. So far, few studies
Externí odkaz:
https://doaj.org/article/869aa6dfcdec43b9ab44d038d3dac136
Autor:
Andreas Trojan, Sven Roth, Ziad Atassi, Michael Kiessling, Reinhard Zenhaeusern, Yannick Kadvany, Johannes Schumacher, Gerd A Kullak-Ublick, Matti Aapro, Alexandru Eniu
Publikováno v:
JMIR Cancer, Vol 10, p e54178 (2024)
BackgroundTrastuzumab has had a major impact on the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC). Anti-HER2 biosimilars such as Ogivri have demonstrated safety and clinical equivalence to trastuzumab (using
Externí odkaz:
https://doaj.org/article/93eadb61cfc44112ad034c037c1f76ca
Autor:
Nora Asper, Kersten Sven Roth, Thomas Frank Hany, Sacha Pierre Salzberg, Marianne Tinguely, Yannick Kadvany, Andreas Trojan
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 1500-1507 (2023)
Introduction: Salivary duct carcinoma (SDC) is an aggressive and rare subtype of salivary gland carcinoma. Surgical excision and radiotherapy are standard of care for early cancer. Chemotherapies with taxanes and platinum show overall response rates
Externí odkaz:
https://doaj.org/article/b4dffc13b4574f70850033b41d67241a
Autor:
Friederike Himmelreich, Alexander Jetter, Michael K. Kiessling, Yannick Kadvany, Andreas Trojan
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 1362-1369 (2023)
Introduction: The awareness and the clinical relevance of the potential interactions between standard and complementary medicine are increasing in medical oncology. Nonetheless, the research and experience of the efficacy, safety, and toxicity of her
Externí odkaz:
https://doaj.org/article/3fead8915604454bb618b3addfde45a5
Autor:
Marcus Vetter, Karin M Rothgiesser, Qiyu Li, Hanne Hawle, Wolfgang Schönfeld, Karin Ribi, Salome Riniker, Roger von Moos, Andreas Trojan, Elena Kralidis, Mathias Fehr, Andreas Müller, Beat Thürlimann
Publikováno v:
Endocrine Oncology, Vol 2, Iss 1, Pp 9-18 (2023)
Objective: CR1447, a novel transdermal formulation of 4-hydroxytestosterone, has aromatase-inhibiting and androgen receptor (AR)-modulating properties (IC50 4.4 nM) with antitumor effects against AR-positive tumor cells in vitro. This trial investiga
Externí odkaz:
https://doaj.org/article/ee02a98a152e445a96fded14df8d50d3
Autor:
Cristina Zarotti, Bärbel Papassotiropoulos, Constanze Elfgen, Konstantin Dedes, Denise Vorburger, Bernhard Pestalozzi, Andreas Trojan, Zsuzsanna Varga
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-14 (2022)
Abstract Breast cancer is a biologically diverse disease with treatment modalities selected based on tumor stage and tumor biology. Distinct intrinsic subtypes and surrogate biomarker profiles play a major role for therapeutic decisions. Response rat
Externí odkaz:
https://doaj.org/article/60b99acd802545f99e679a550862afa5
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 1, Pp 616-621 (2021)
Effective treatment options are still scarce for metastatic triple-negative breast cancers. An increasing interest in the mutational landscape of this disease will facilitate novel therapeutic strategies in a variety of cancers. Here we report the ca
Externí odkaz:
https://doaj.org/article/9cc17d57a54e47c583662dacab5ad5cb
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 2, Pp 491-496 (2020)
Digital patient monitoring gains importance for quality of clinical cancer care. Our case report provides insight into usability and acceptance of a smartphone app for monitoring of electronically captured patient-reported outcomes in patients underg
Externí odkaz:
https://doaj.org/article/6ffd2dbdeda84bb6b8f8d1226e47a00d
Autor:
Andreas Trojan, Nicolas Leuthold, Christoph Thomssen, Achim Rody, Thomas Winder, Andreas Jakob, Claudine Egger, Ulrike Held, Christian Jackisch
Publikováno v:
Journal of Medical Internet Research, Vol 23, Iss 8, p e29271 (2021)
BackgroundElectronic patient-reported outcomes (ePRO) are a relatively novel form of data and have the potential to improve clinical practice for cancer patients. In this prospective, multicenter, observational clinical trial, efforts were made to de
Externí odkaz:
https://doaj.org/article/e673b6a950fc40af815df08da0240fda